Significance of molecular biomarkers in idiopathic pulmonary fibrosis: A mini review

This publication has 46 references indexed in Scilit:

• An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
  American Journal of Respiratory and Critical Care Medicine, 2011
• Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias
  European Respiratory Journal, 2010
• Gene Expression Profiles of Acute Exacerbations of Idiopathic Pulmonary Fibrosis
  American Journal of Respiratory and Critical Care Medicine, 2009
• Serum Surfactant Protein-A Is a Strong Predictor of Early Mortality in Idiopathic Pulmonary Fibrosis
  Chest, 2009
• Serum markers in interstitial pneumonia with and without Pneumocystis jiroveciicolonization: a prospective study
  BMC Infectious Diseases, 2009
• MMP1 and MMP7 as Potential Peripheral Blood Biomarkers in Idiopathic Pulmonary Fibrosis
  PLOS Medicine, 2008
• Increased levels of KL‐6 and subsequent mortality in patients with interstitial lung diseases
  Journal of Internal Medicine, 2006
• Circulating KL-6 levels in patients with drug induced pneumonitis
  Thorax, 2003
• Aberrant Appearance of Lung Surfactant Protein A in Sera of Patients with Idiopathic Pulmonary Fibrosis and Its Clinical Significance
  Respiration, 1995
• Alveolar-to-Vascular Leakage of Surfactant Protein A in Ventilated Immature Newborn Rabbits
  Neonatology, 1995